Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Universal mRNA-based HIV Vaccine for Acute and Latent Infections

Version 1 : Received: 15 March 2024 / Approved: 18 March 2024 / Online: 18 March 2024 (11:24:43 CET)

How to cite: Niazi, S.K.; Magoola, M. Universal mRNA-based HIV Vaccine for Acute and Latent Infections. Preprints 2024, 2024031035. https://doi.org/10.20944/preprints202403.1035.v1 Niazi, S.K.; Magoola, M. Universal mRNA-based HIV Vaccine for Acute and Latent Infections. Preprints 2024, 2024031035. https://doi.org/10.20944/preprints202403.1035.v1

Abstract

Human Immunodeficiency Virus (HIV) infection and its latent recurrent infection make vaccine development a significant challenge for traditional vaccines; however, the mRNA delivery of multiepitope antigens capable of creating antibodies against the surface proteins of HIV-1 and HIV-2 along with their respective Nef proteins, responsible for the latent infection can bring a most effective, as well as affordable solution to the unresolved epidemics of HIV. In this paper, we present the complete design of a multiepitope vaccine to prevent acute infections and inactivate Nef proteins that block the MHC-1 and MHC-2 pathways to hide the virus for later reinfection.

Keywords

HIV-1 1; HIV-2 2; surface proteins 3; Nef proteins 4; mRNA delivery 5; Universal vaccine.

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.